Terremoto Bio

About Terremoto Bio

Terremoto Bio is a biotechnology company focused on covalent chemistry to discover and develop superior small molecule medicines. The company emphasizes novel covalency technologies to deliver selective, safe oral therapies targeting disease biology, with a focus on oncology and related conditions. Its work centers on advancing drug discovery and development through deep medicinal chemistry and targeted covalent inhibition, aiming to set new standards for therapeutic efficacy and safety. Terremoto Bio communicates a bold, earthquake-inspired approach to transforming small-molecule therapeutics and patient outcomes, with activities spanning research, pipeline development, and clinical strategy.